In this Q&A, Latent Labs CEO and AlphaFold co-developer Simon Kohl explains how generative A.I. is transforming biology from a science of prediction to one of design, why programmable drug discovery represents a new era in biotech and how the shift from computation to creation is redefining the boundaries of scientific innovation.
Backed by top investors, Periodic Labs aims to create an A.I. scientist by combining machine learning with real-world experiments in the physical sciences.